ÂÜÀòÂÒÂ×

Madhu Lal Nag, MBS PhD has extensive work experience in the biopharmaceutical and scientific research fields. Their most recent role was as the Chief Scientific Officer - Discovery at InSphero since February 2023. Prior to that, they worked as the Director of Translational Research at Day One Biopharmaceuticals from September 2021 to February 2023. They also served as a Program Lead at the FDA from December 2018 to September 2021.

From 2014 to 2018, Madhu Lal Nag worked at the National Center for Advancing Translational Sciences (NCATS) in various roles. They were the Head of the Trans NIH RNAi Facility, where they managed scientific, fiscal, and administrative operations. They also served as the Acting Team Lead of the RNAi Screening Facility, where they managed laboratory operations and facilitated collaborative projects with NIH investigators. Additionally, Madhu Lal Nag worked as a Research Scientist, focusing on developing assays in cancer and stem cell biology.

Before their time at NCATS, Madhu Lal Nag was a Postdoctoral Fellow at the National Center for Advancing Translational Sciences (NCATS/NIH) from 2013 to 2014. They also held the position of Vice-President of Membership at the Global Alliance of Indian Biomedical Professionals from September 2012 to February 2014.

In terms of professional associations, Madhu Lal Nag was an Associate Faculty member at Faculty of 1000 from March 2010 to July 2013. They also served as a Postdoctoral Research Scientist at the National Institutes of Health from June 2009 to December 2012.

Outside of their research roles, they held leadership positions in organizations such as Graduate Women in Science, where they served as the President from June 2011 to June 2012. They were responsible for overseeing the financial health of the organization and establishing international chapters. They also served as an Alumni Board Member at Keck Graduate Institute from October 2009 to October 2011, maintaining relationships with alumni and identifying job opportunities for graduates.

Overall, Madhu Lal Nag has a diverse background in scientific research, leadership, and management in the biopharmaceutical industry and academic institutions.

Madhu Lal Nag's education history is as follows:

Madhu Lal Nag attended Loreto House, although the specific dates are unknown. Following this, they enrolled in Mumbai University, St. Xaviers from 1996 to 1999, where they earned a Bachelor of Science (B.S.) degree with a focus on Microbiology/Biochemistry.

In 2000, Madhu Lal Nag continued their education at Mumbai University, Institute of Science, where they completed a Master of Science (M.S.) degree in Biochemistry. Madhu then pursued further studies at Keck Graduate Institute of Applied Life Sciences from 2002 to 2004, earning a Master of Bioscience (M.B.S.) degree with a specialization in Management and Biosciences.

Madhu Lal Nag embarked on a doctoral program at The George Washington University from 2004 to 2009. In the Institute of Biomedical Sciences, they obtained a Doctor of Philosophy (PhD) degree, specializing in Molecular and Cellular Oncology.

In 2011, Madhu Lal Nag briefly attended Montgomery College for Chief Science Officer-Scientific Management Training, but no degree was specified.

Based on the provided chronological information, this constitutes Madhu Lal Nag's education history.